Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: J Neuroimmunol. 2020 Apr 27;344:577246. doi: 10.1016/j.jneuroim.2020.577246

Table 3.

Cytometry changes in HIV+ participants at 24 week visit. Blood cells are per microliter and CSF cells are per milliliter.

Visit 1 Visit 2 P value
Blood cell type
CD4+ 189 (68–523) 358 (165–479) 0.0002*
%CD4+ that are HLADR+ 15 (12–25) 8 (5–13) 0.007*
CD8+ 672 (457–1484) 772 (603–1089) 0.80
%CD8+ that are HLADR+ 15 (7–25) 7 (2–9) 0.001*
CD4/CD8 0.19 (0.13–0.34) 0.41 (0.22–0.65) 0.021*
CD19+ 163 (94–296) 300 (182–464) 0.007*
NK 91 (64–154) 118 (69–154) 0.99
Monocytes total 325 (227–436) 312 (195–415) 0.31
Monocytes (%classical) 75% (68%–85%) 81% (72%–86%) 0.25
Monocytes (%intermediate) 11% (6%–15%) 5% (3%–8%) 0.01*
Monocytes (%non-classical) 12% (6%–18%) 12% (10%–17%) 0.55
CSF cell type
CD4 593 (56–1472) 391 (116–731) 0.09
%CD4+ that are HLADR+ 13 (9–24) 7 (6–10) 0.003*
CD8 1696 (316–5800) 797 (329–1579) 0.006*
%CD8+ that are HLADR+ 16 (6–25) 6 (2–8) 0.0003*
CD4/CD8 0.34 (0.11–0.55) 0.44 (0.35–0.64) 0.02*
CD19 94 (31–270) 42 (21–57) 0.002*
NK 53 (16–89) 16 (10–39) 0.027*
Monocytes total 39 (15–55) 23 (10–62) 0.39
Monocytes (%classical) 30% (25%–36%) 37% (25%–43%) 0.42
Monocytes (%intermediate) 54% (43%–63%) 57% (49%–67%) 0.45
Monocytes (%non-classical) 13% (9%–19%) 8% (6%–14%) 0.03*

P values < .05 are denoted by asterisk.